Get Live Data

George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here. 

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Oxford Biodyn Share Price
  4. Oxford Biodyn Share Regulatory News

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Oxford Biodyn Information

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.38 (4.691%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.10
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1234567
Date   Source Headline
18th Sep 20187:00 amRNSConsortium with OBD receives ?4m Horizon 2020 fund
4th Sep 201810:03 amRNSTotal Voting Rights
30th Aug 20182:57 pmRNSHolding(s) in Company
29th Aug 20184:52 pmRNSHolding(s) in Company
29th Aug 20184:48 pmRNSHolding(s) in Company
29th Aug 20184:47 pmRNSHolding(s) in Company
29th Aug 20184:46 pmRNSHolding(s) in Company
29th Aug 20184:43 pmRNSHolding(s) in Company
22nd Aug 20187:00 amRNSChinese Investment Group Takes Stake in OBD
19th Jul 20187:00 amRNSGrant of Canadian patent for EpiSwitch platform
17th Jul 20187:00 amRNSOBD presents latest EpiSwitch data at ASH Summit
2nd Jul 20185:50 pmRNSTotal Voting Rights
26th Jun 20187:00 amRNSALS study published in peer reviewed journal
19th Jun 20187:00 amRNSIssue of Equity
22nd May 20187:00 amRNSInterim Results for the Period Ended 31 March 2018
1st May 20187:00 amRNSTotal Voting Rights
17th Apr 20187:00 amRNSNotice of Interim Results
5th Apr 201811:41 amRNSIssue of Equity
28th Mar 20187:00 amRNSPublication in Journal of Translational Medicine
19th Mar 20187:00 amRNSPDMR Dealing/Grant of Share Options
16th Mar 20187:00 amRNSALS biomarker data presented at World CNS Summit
15th Mar 20182:10 pmRNSResults of Annual General Meeting
15th Feb 20187:00 amRNSPublication of Annual Report and Notice of AGM
14th Feb 20181:11 pmRNSGrant of Indian patent for EpiSwitch platform
30th Jan 20187:01 amRNSShore Capital appointed as NOMAD and Sole Broker
30th Jan 20187:00 amRNSFinal Results for the Year Ended 30 September 2017
29th Jan 20187:00 amRNSCollaboration in sports-related concussions
16th Jan 20187:00 amRNSNotice of Results
5th Jan 20183:05 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSSigns 2nd agreement with US biopharma company
2nd Jan 20183:00 pmRNSTotal Voting Rights
21st Dec 20177:00 amRNSDirector/PDMR Shareholding
13th Dec 20177:01 amRNSExercise period extension existing Share Options
5th Dec 20177:00 amRNSEXERCISE OF WARRANTS AND DIRECTOR DEALING
15th Nov 20177:00 amRNSData at FNIH Biomarker Consortium Cancer Meeting
7th Nov 20177:00 amRNSAgreement with a major US biopharma company
6th Nov 201712:29 pmRNSNotification of major holdings
13th Oct 20177:00 amRNSPresents at the Diabetes Asia 2017 Conference
11th Oct 20177:00 amRNSPresents ALS signatures at NEALS
3rd Oct 20177:00 amRNSAnnounces grant of US patent for EpiSwitchT
28th Sep 20177:00 amRNSSuccessful in diagnosing and staging breast cancer
15th Sep 20177:00 amRNSDirectorate Update
30th Jun 20177:00 amRNSAppointment of Paul Stockdale as CFO
13th Jun 20177:00 amRNSInterim Results
13th Jun 20177:00 amRNSTargets Amyotrophic Lateral Sclerosis in Asia
31st May 20177:00 amRNSNotice of Interim Results
31st May 20177:00 amRNSPublication highlights advantages of EpiSwitchT
23rd May 20177:00 amRNSDevelopment Agreements with Top Pharma Companies
19th May 20177:00 amRNSAppointment of Shore Capital as Joint Broker
18th May 20177:00 amRNSSubsidiary signs exclusive Asia licence
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.